Syndicated from Biovation’s Website
FOR RELEASE: IMMEDIATE
Seitz will lead Biovation’s sales thrust as it launches new medical devices and products and engages with global partners
BOOTHBAY, ME – Biovation, a manufacturer of biopolymer non-woven fiber products for medical, packaging, and specialty markets, announces that Keri Seitz has joined the executive management team as Vice President of Sales and Customer Relations. Seitz brings experience in the medical device marketplace to her new role, where she is responsible for growing and managing the sales organization, providing strategic direction for Biovation’s emerging partner and distributor network, and continuing the company’s growth plans.
Seitz previously served as President and CEO of FHC, a manufacturer and developer of products used in neuroscience research and neurosurgical procedures. During her tenure, the company increased revenue by almost forty percent and quadrupled net operating profit. She has extensive experience in Quality Management Systems, specifically with ISO 13485 compliance and implementation, and is knowledgeable in global medical device registration and compliance.
“I am incredibly excited that Keri has joined our team and will lead our tactical and strategic global sales efforts. During the last several years we have engaged with customers who are leaders in their market sectors, and now plan to leverage those relationships and applicable products to the larger marketplace,”
says Biovation Chief Executive Officer Kerem Durdag.
”Keri is the right person to lead us in our next stage of growth given her deep experience in delivering rapid revenue growth and increasing market share through highly effective results-oriented sales practices.”
Seitz will help Biovation release several new products within this calendar year, including an infection control barrier product (the BioArmour™ Blood Pressure Cuff Shield), a specialty advanced product for the Department of Defense (the DryRight™), and several roll goods products for niche markets.
About Anania & Associates Investment Company LLC
Anania & Associates Investment Company LLC (AAI) is a Maine based and focused private equity firm that partners with management teams acquiring and building companies with a high potential for growth. Founded in 2008 the fund currently has 8 portfolio companies representing over 450 employees and $75 million in revenue. AAI is a long term, regionally focused investor focused on supporting sustainable growth for its portfolio companies which include: Biovation II LLC, Elmet Technologies LLC, Grow-Tech LLC, Lighthouse Imaging LLC, MEGA Industries LLC, mWAVE Industries LLC, Synergistic Software Solutions LLC & TrakTec LLC.
About Biovation LLC
Biovation is a technology design and manufacturing company that manufactures advanced polylactic acid (PLA)-based non-woven fiber end products and roll goods with integrated antimicrobial properties for packaging, infection control, advanced wound care, hygiene, and other specialty applications. Biovation has extensive experience with green biopolymers such as, PLA, which comes from cornstarch and is completely biodegradable. For more information, call +1.207.633.0616 or visit www.biovation.com.
CONTACT: Kerem Durdag: firstname.lastname@example.org; 207.632.2559